Shouyao Holdings (Beijing) Co. Ltd. A (688197) - Total Assets
Based on the latest financial reports, Shouyao Holdings (Beijing) Co. Ltd. A (688197) holds total assets worth CN¥819.45 Million CNY (≈ $119.91 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See shareholders equity of Shouyao Holdings (Beijing) Co. Ltd. A for net asset value and shareholders' equity analysis.
Shouyao Holdings (Beijing) Co. Ltd. A - Total Assets Trend (2019–2024)
This chart illustrates how Shouyao Holdings (Beijing) Co. Ltd. A's total assets have evolved over time, based on quarterly financial data.
Shouyao Holdings (Beijing) Co. Ltd. A - Asset Composition Analysis
Current Asset Composition (December 2024)
Shouyao Holdings (Beijing) Co. Ltd. A's total assets of CN¥819.45 Million consist of 84.6% current assets and 15.4% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 2.5% |
| Accounts Receivable | CN¥91.12K | 0.0% |
| Inventory | CN¥3.41 Million | 0.4% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥303.88K | 0.0% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2019–2024)
This chart illustrates how Shouyao Holdings (Beijing) Co. Ltd. A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Shouyao Holdings (Beijing) Co. Ltd. A.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shouyao Holdings (Beijing) Co. Ltd. A's current assets represent 84.6% of total assets in 2024, a decrease from 94.8% in 2019.
- Cash Position: Cash and equivalents constituted 2.5% of total assets in 2024, down from 64.9% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2019.
- Asset Diversification: The largest asset category is inventory at 0.4% of total assets.
Shouyao Holdings (Beijing) Co. Ltd. A Competitors by Total Assets
Key competitors of Shouyao Holdings (Beijing) Co. Ltd. A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Fortress Biotech Inc
NASDAQ:FBIO
|
USA | $185.55 Million |
|
Summit Therapeutics PLC
NASDAQ:SMMT
|
USA | $261.73 Million |
|
Tubize-Fin
BR:TUB
|
Belgium | €1.93 Billion |
|
Apellis Pharmaceuticals Inc
NASDAQ:APLS
|
USA | $1.08 Billion |
|
Beijing Tiantan Biological Products Corp Ltd
SHG:600161
|
China | CN¥16.55 Billion |
|
BrightGene Bio Medical Technology C
SHG:688166
|
China | CN¥5.38 Billion |
|
BioArctic AB (publ)
ST:BIOA-B
|
Sweden | Skr2.60 Billion |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
Shouyao Holdings (Beijing) Co. Ltd. A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.16 | 7.48 | 14.78 |
| Quick Ratio | 6.13 | 7.47 | 14.74 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥589.30 Million | CN¥679.17 Million | CN¥1.32 Billion |
Shouyao Holdings (Beijing) Co. Ltd. A - Advanced Valuation Insights
This section examines the relationship between Shouyao Holdings (Beijing) Co. Ltd. A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 9.25 |
| Latest Market Cap to Assets Ratio | 0.96 |
| Asset Growth Rate (YoY) | -17.1% |
| Total Assets | CN¥922.23 Million |
| Market Capitalization | $888.99 Million USD |
Valuation Analysis
Near Book Valuation: The market values Shouyao Holdings (Beijing) Co. Ltd. A's assets close to their book value (0.96x), suggesting investors view the company's assets at approximately fair value.
Significant Asset Reduction: Shouyao Holdings (Beijing) Co. Ltd. A's assets decreased by 17.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Shouyao Holdings (Beijing) Co. Ltd. A (2019–2024)
The table below shows the annual total assets of Shouyao Holdings (Beijing) Co. Ltd. A from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥922.23 Million ≈ $134.95 Million |
-17.07% |
| 2023-12-31 | CN¥1.11 Billion ≈ $162.74 Million |
-14.40% |
| 2022-12-31 | CN¥1.30 Billion ≈ $190.12 Million |
+2133.32% |
| 2021-12-31 | CN¥58.18 Million ≈ $8.51 Million |
-68.06% |
| 2020-12-31 | CN¥182.13 Million ≈ $26.65 Million |
-16.79% |
| 2019-12-31 | CN¥218.89 Million ≈ $32.03 Million |
-- |
About Shouyao Holdings (Beijing) Co. Ltd. A
Shouyao Holdings (Beijing) Co., LTD. engages in the research, development, and production of innovative drugs in China. The company offers drugs for various indications, including non-small cell lung cancer, lymphoma, hepatocellular carcinoma, pancreatic cancer, breast cancer, ovarian cancer, thyroid cancer, leukemia, and diabetes. The company was founded in 2016 and is headquartered in Beijing, … Read more